Taiwan’s AppWorks Leads $1M Round In Vietnam Healthtech Startup Docosan Vietnam-based healthtech startup Docosan has raised over US$1 million in a funding round led by Taiwanese tech venture capital firm AppWorks, which is known for its investments in leading Southeast Asian companies such as Lalamove, Carousell, and ShopBack.
Chinese Surgical Robot Developer EDDA Raises $150M Led By SoftBank Vision Fund 2 EDDA Technology, a developer of intelligent robotic solutions for precision surgery, has raised $150 million in a round led by SoftBank Vision Fund 2. The company will use the proceeds to further its ambition of combining precision surgery with AI and robotics for better patient outcomes in China and worldwide.
Indian Telehealth Platform Mfine Raises $16M From Heritas Capital, And Existing Backers Amid a year of pandemic restrictions, India’s telemedicine startup Mfine has raised $16 million in its latest funding round led by Singapore-based investor Heritas Capital and family office Y’S Investment. Existing investors who also participated in the fundraising exercise include SBI Investment, SBI Ven Capital BEENEXT, and Alteria Capital, the company said in a statement.
Israeli Eyecontrol Raises $7.5 Million for Its AI-Powered Communication Solution for Ventilated Patients EyeControl developed a wearable, screenless assistive communication device. AI-powered eye-tracking technology enables remote communication between ventilated ICU patients, their families, and medical care teams.
Israeli Sight Diagnostics Raises $71 Million Amidst Covid-19 Demand for Blood Count Devices Sight isn't involved in Covid-19 detection, but its complete blood count (CBC) test is being used across the world to help treat coronavirus patients who require constant testing to determine their condition.
Singapore's NDR Medical Raises US$5.8M to Expand Its Smart Surgical Robots Business to China, US NDR will use the capital to prepare for the expansion into the US, regulatory submission across other major markets, as well as to further enhance the team's technical capabilities and explore other clinical applications for the product.